AVROBIO, Inc. Files 8-K Report
Ticker: TECX · Form: 8-K · Filed: Jun 14, 2024 · CIK: 1681087
| Field | Detail |
|---|---|
| Company | Avrobio, Inc. (TECX) |
| Form Type | 8-K |
| Filed Date | Jun 14, 2024 |
| Risk Level | low |
| Pages | 5 |
| Reading Time | 6 min |
| Key Dollar Amounts | $0.0001, $0 |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 8-k
TL;DR
AVROBIO filed an 8-K, likely an update on business/financials. No major news yet.
AI Summary
On June 14, 2024, AVROBIO, Inc. filed an 8-K report. The filing indicates that the company is providing an update on its business and financial condition. No specific material events or transactions were detailed in the provided excerpt.
Why It Matters
This filing serves as an official update from AVROBIO, Inc. to the SEC, informing investors about the company's current status.
Risk Assessment
Risk Level: low — The filing is a standard 8-K report and does not contain information that inherently increases risk.
Key Players & Entities
- AVROBIO, Inc. (company) — Registrant
- June 14, 2024 (date) — Date of Report
- 001-38537 (other) — Commission File Number
- 81-0710585 (other) — I.R.S. Employer Identification No.
- Cambridge, MA (location) — Principal Executive Offices
FAQ
What is the purpose of this 8-K filing for AVROBIO, Inc.?
The 8-K filing is a current report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934, indicating an update on the company's business and financial condition as of June 14, 2024.
What is AVROBIO, Inc.'s principal executive office address?
AVROBIO, Inc.'s principal executive offices are located at One Broadway, 14th Floor, Cambridge, MA 02142.
What is AVROBIO, Inc.'s telephone number?
AVROBIO, Inc.'s telephone number is (617) 914-8420.
What is the Commission File Number for AVROBIO, Inc.?
The Commission File Number for AVROBIO, Inc. is 001-38537.
When was AVROBIO, Inc. incorporated or organized?
AVROBIO, Inc. is incorporated in Delaware.
Filing Stats: 1,566 words · 6 min read · ~5 pages · Grade level 16.1 · Accepted 2024-06-14 16:30:55
Key Financial Figures
- $0.0001 — nge on which registered Common Stock, $0.0001 par value per share AVRO Nasdaq Glo
- $0 — shares of AVRO common stock, par value $0.0001, per share of AVRO (" Common Stock
Filing Documents
- d844856d8k.htm (8-K) — 31KB
- 0001193125-24-161663.txt ( ) — 153KB
- avro-20240614.xsd (EX-101.SCH) — 3KB
- avro-20240614_lab.xml (EX-101.LAB) — 18KB
- avro-20240614_pre.xml (EX-101.PRE) — 11KB
- d844856d8k_htm.xml (XML) — 4KB
Forward-Looking Statements
Forward-Looking Statements This Current Report on Form 8-K and the exhibits filed or furnished herewith contain "forward-looking statements" within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995, including but not limited to, express or implied statements regarding the structure, timing and completion of the Merger or Reverse Stock Split; the combined company's listing on Nasdaq after the closing of the proposed Merger (the "Closing"); expectations regarding the ownership structure of the combined company; the anticipated timing of the Closing; and other statements that are not historical fact. All statements other than statements of historical fact contained in this Current Report on Form 8-K and the exhibits filed or furnished herewith are forward-looking statements. These forward-looking statements are made as of the date they were first issued, and were based on the then-current expectations, estimates, forecasts, and projections, as well as the beliefs and assumptions of management. There can be no assurance that future developments affecting AVRO, Tectonic, the Merger or the private placement financings will be those that have been anticipated. Forward-looking statements are subject to a number of risks and uncertainties, many of which involve factors or circumstances that are beyond AVRO's control. AVRO's actual results could differ materially from those stated or implied in forward-looking statements due to a number of factors, including but not limited to the risk that the conditions to the Closing are not satisfied. Actual results and the timing of events could differ materially from those anticipated in such forward-looking statements as a result of these risks and uncertainties. These and other risks and uncertainties are more fully described in periodic filings with the SEC, including the factors described in the section titled "Risk Factors" in AVRO's Annual Report on Form 10-K for the year ended